WIRB-Copernicus IRB will give priority to the institutional review board (IRB) review of potentially life-saving COVID-19 vaccines and medications and waive their initial protocol review fees
Researchers' work is providing crucial leads for guiding experimental efforts toward the vaccine development against the novel pneumonia (COVID-19) caused by the virus
Highly scalable kits enable researchers to prepare liquid-stable antigen and antibody conjugates with a wide range of labels including enzymes, fluorochromes, and biotin
Study is the first to experimentally determine which byproducts from the mutation of tumors have the ability to provoke the immune system into recognizing and killing cancer cells in multiple myeloma patients